Paper33763448
Microfluidics in Sickle Cell Disease Research: State of the Art and a Perspective Beyond the Flow Problem.
Aich A and 5 others. Front Mol Biosci, 2020. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Microfluidics in Sickle Cell Disease Research: State of the Art and a Perspective Beyond the Flow Problem. Papers, record 33763448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33763448
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Microfluidics in Sickle Cell Disease Research: State of the Art and a Perspective Beyond the Flow Problem.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References110
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20455701 | Sickle cell biomechanics. | Annu Rev Biomed Eng | 2010 | https://conductscience.org/library/papers/20455701 | PubMed |
| 2 | 24589270 | Cellular adhesion and the endothelium: E-selectin, L-selectin, and pan-selectin inhibitors. | Hematol Oncol Clin North Am | 2014 | https://conductscience.org/library/papers/24589270 | PubMed |
| 3 | 28658717 | Bone marrow-on-a-chip: Long-term culture of human haematopoietic stem cells in a three-dimensional microfluidic environment. | J Tissue Eng Regen Med | 2018 | https://conductscience.org/library/papers/28658717 | PubMed |
| 4 | 26928437 | Innovation in the pharmaceutical industry: New estimates of R&D costs. | J Health Econ | 2016 | https://conductscience.org/library/papers/26928437 | PubMed |
| 5 | 15389823 | Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. | Am J Hematol | 2004 | https://conductscience.org/library/papers/15389823 | PubMed |
| 6 | 32346864 | Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease. | Br J Haematol | 2020 | https://conductscience.org/library/papers/32346864 | PubMed |
| 7 | 31988458 | Robotic fluidic coupling and interrogation of multiple vascularized organ chips. | Nat Biomed Eng | 2020 | https://conductscience.org/library/papers/31988458 | PubMed |
| 8 | 27161653 | Extracellular microvesicle microRNAs in children with sickle cell anaemia with divergent clinical phenotypes. | Br J Haematol | 2016 | https://conductscience.org/library/papers/27161653 | PubMed |
| 9 | 28617487 | Organ-on-a-chip devices advance to market. | Lab Chip | 2017 | https://conductscience.org/library/papers/28617487 | PubMed |
| 10 | 29542687 | Sickle cell disease. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29542687 | PubMed |
| 11 | 1402324 | Endothelial adhesivity of sickle red blood cells. | J Lab Clin Med | 1992 | https://conductscience.org/library/papers/1402324 | PubMed |
| 12 | 32208292 | Leukocyte adhesion to P-selectin and the inhibitory role of Crizanlizumab in sickle cell disease: A standardized microfluidic assessment. | Blood Cells Mol Dis | 2020 | https://conductscience.org/library/papers/32208292 | PubMed |
| 13 | 31934320 | The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease. | Mediterr J Hematol Infect Dis | 2020 | https://conductscience.org/library/papers/31934320 | PubMed |
| 14 | 30265442 | Mouse Models of Pain in Sickle Cell Disease. | Curr Protoc Neurosci | 2018 | https://conductscience.org/library/papers/30265442 | PubMed |
| 15 | 30355263 | Emerging Genetic Therapy for Sickle Cell Disease. | Annu Rev Med | 2019 | https://conductscience.org/library/papers/30355263 | PubMed |
| 16 | 28376286 | Microfluidics for investigating vaso-occlusions in sickle cell disease. | Microcirculation | 2017 | https://conductscience.org/library/papers/28376286 | PubMed |
| 17 | 25202042 | The intercellular cell adhesion molecule-1 (icam-1) in lung cancer: implications for disease progression and prognosis. | Anticancer Res | 2014 | https://conductscience.org/library/papers/25202042 | PubMed |
| 18 | 25605910 | Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25605910 | PubMed |
| 19 | 2672967 | Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle cell anemia. | Ann N Y Acad Sci | 1989 | https://conductscience.org/library/papers/2672967 | PubMed |
| 20 | 31616534 | Brain-on-a-chip: A history of development and future perspective. | Biomicrofluidics | 2019 | https://conductscience.org/library/papers/31616534 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42890342 | Human erythroid models of sickle cell disease. | Hemasphere | 2026 | https://conductscience.org/library/papers/42890342 | PubMed |
| 41111336 | Evaluating anti-sickling therapies for sickle cell disease: a microfluidic assay for red blood cell-mediated microvascular occlusion under hypoxia. | Lab Chip | 2025 | https://conductscience.org/library/papers/41111336 | PubMed |
| 40439782 | Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease. | Ann Intensive Care | 2025 | https://conductscience.org/library/papers/40439782 | PubMed |
| 40437545 | The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape. | Ital J Pediatr | 2025 | https://conductscience.org/library/papers/40437545 | PubMed |
| 40195326 | Low-cost optical sensors in electrified lab-on-a-disc platforms: liquid-phase boundary detection and automated diagnostics. | Microsyst Nanoeng | 2025 | https://conductscience.org/library/papers/40195326 | PubMed |
| 38487919 | Next generation microfluidics: fulfilling the promise of lab-on-a-chip technologies. | Lab Chip | 2024 | https://conductscience.org/library/papers/38487919 | PubMed |
| 36829507 | Anticancer Drugs Paclitaxel, Carboplatin, Doxorubicin, and Cyclophosphamide Alter the Biophysical Characteristics of Red Blood Cells, In Vitro. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/36829507 | PubMed |
| 36296012 | Fabrication and Manipulation of Non-Spherical Particles in Microfluidic Channels: A Review. | Micromachines (Basel) | 2022 | https://conductscience.org/library/papers/36296012 | PubMed |
| 36134985 | Extracellular Vesicles in Sickle Cell Disease: A Promising Tool. | Bioengineering (Basel) | 2022 | https://conductscience.org/library/papers/36134985 | PubMed |
| 35207138 | Microfluidics Approach to the Mechanical Properties of Red Blood Cell Membrane and Their Effect on Blood Rheology. | Membranes (Basel) | 2022 | https://conductscience.org/library/papers/35207138 | PubMed |
| 34944060 | Microfluidic Characterization of Red Blood Cells Microcirculation under Oxidative Stress. | Cells | 2021 | https://conductscience.org/library/papers/34944060 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33763448
GET https://conductscience.org/api/papers/v1/33763448/references?page=2